Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine

Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

(2021) Messoud Ashina et al.   CEPHALALGIA

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan

(2020) David Kudrow et al.   HEADACHE

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine

(2019) Peter J Goadsby et al.   BRAIN

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

(2019) John H Krege et al.   CEPHALALGIA

Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)

(2019) Jan Lewis Brandes et al.   CEPHALALGIA

Lasmiditan is an effective acute treatment for migraine

(2018) Bernice Kuca et al.   NEUROLOGY

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY